Current Practice in Managing Patients on Anticoagulants and/or Antiplatelet Agents around the Time of Gastrointestinal Endoscopy
P Mosler, K Mergener, U Denzer… - Zeitschrift für …, 2004 - thieme-connect.com
In der Therapie kardiovaskulärer Erkrankungen sind orale Antikoagulantien (AC) und
Thrombozytenfunktionshemmer (TFH) weit verbreitet. Wird bei Patienten, die solche …
Thrombozytenfunktionshemmer (TFH) weit verbreitet. Wird bei Patienten, die solche …
Current practice in managing patients on anticoagulants and/or antiplatelet agents around the time of gastrointestinal endoscopy--a nation-wide survey in Germany.
P Mosler, K Mergener, U Denzer… - Zeitschrift fur …, 2004 - europepmc.org
Anticoagulants and antiplatelet agents are widely used in the prophylaxis and management
of thromboembolic and cardiovascular diseases. Gastrointestinal bleeding is a well-known …
of thromboembolic and cardiovascular diseases. Gastrointestinal bleeding is a well-known …
[引用][C] Current practice in managing patients on anticoagulants and/or antiplatelet agents around the time of gastrointestinal endoscopy-a nation-wide survey in …
P MOSLER - Z Gastroenterol, 2004 - cir.nii.ac.jp
Current practice in managing patients on anticoagulants and/or antiplatelet agents around
the time of gastrointestinal endoscopy-a nation-wide survey in germany | CiNii Research …
the time of gastrointestinal endoscopy-a nation-wide survey in germany | CiNii Research …
Current practice in managing patients on anticoagulants and/or antiplatelet agents around the time of gastrointestinal endoscopy--a nation-wide survey in Germany
P Mosler, K Mergener, U Denzer… - Zeitschrift fur …, 2004 - pubmed.ncbi.nlm.nih.gov
Anticoagulants and antiplatelet agents are widely used in the prophylaxis and management
of thromboembolic and cardiovascular diseases. Gastrointestinal bleeding is a well-known …
of thromboembolic and cardiovascular diseases. Gastrointestinal bleeding is a well-known …